276 related articles for article (PubMed ID: 36399165)
1. Inclusion body myositis: from genetics to clinical trials.
Nagy S; Khan A; Machado PM; Houlden H
J Neurol; 2023 Mar; 270(3):1787-1797. PubMed ID: 36399165
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic spectrum of inclusion body myositis.
Roy B; Dimachkie MM; Naddaf E
Clin Exp Rheumatol; 2024 Feb; 42(2):445-453. PubMed ID: 38436356
[TBL] [Abstract][Full Text] [Related]
3. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches.
Needham M; Mastaglia FL
Lancet Neurol; 2007 Jul; 6(7):620-31. PubMed ID: 17582362
[TBL] [Abstract][Full Text] [Related]
4. Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis.
Michelle EH; Pinal-Fernandez I; Casal-Dominguez M; Albayda J; Paik JJ; Tiniakou E; Adler B; Mecoli CA; Danoff SK; Christopher-Stine L; Mammen AL; Lloyd TE
Neurology; 2023 Mar; 100(13):e1406-e1417. PubMed ID: 36690456
[TBL] [Abstract][Full Text] [Related]
5. Inclusion body myositis in twins.
Amato AA; Shebert RT
Neurology; 1998 Aug; 51(2):598-600. PubMed ID: 9710045
[TBL] [Abstract][Full Text] [Related]
6. Inclusion body myositis.
Dimachkie MM; Barohn RJ
Semin Neurol; 2012 Jul; 32(3):237-45. PubMed ID: 23117948
[TBL] [Abstract][Full Text] [Related]
7. [Inclusion body myositis (IBM) -- a review].
Czaplinski A; Renaud S; Fuhr P
Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
[TBL] [Abstract][Full Text] [Related]
8. Sporadic Inclusion Body Myositis and Other Rimmed Vacuolar Myopathies.
Weihl CC
Continuum (Minneap Minn); 2019 Dec; 25(6):1586-1598. PubMed ID: 31794461
[TBL] [Abstract][Full Text] [Related]
9. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families.
Sivakumar K; Semino-Mora C; Dalakas MC
Brain; 1997 Apr; 120 ( Pt 4)():653-61. PubMed ID: 9153127
[TBL] [Abstract][Full Text] [Related]
10. Inclusion Body Myositis: Update on Pathogenesis and Treatment.
Naddaf E; Barohn RJ; Dimachkie MM
Neurotherapeutics; 2018 Oct; 15(4):995-1005. PubMed ID: 30136253
[TBL] [Abstract][Full Text] [Related]
11. Familial inflammatory inclusion body myositis.
Ranque-Francois B; Maisonobe T; Dion E; Piette JC; Chauveheid MP; Amoura Z; Papo T
Ann Rheum Dis; 2005 Apr; 64(4):634-7. PubMed ID: 15769920
[TBL] [Abstract][Full Text] [Related]
12. Inclusion body myositis: therapeutic approaches. A case report.
Kierdaszuk B; Kamińska A
Neurol Neurochir Pol; 2011; 45(1):68-73. PubMed ID: 21384296
[TBL] [Abstract][Full Text] [Related]
13. Inclusion body myositis and sarcoid myopathy: coincidental occurrence or associated diseases.
Sanmaneechai O; Swenson A; Gerke AK; Moore SA; Shy ME
Neuromuscul Disord; 2015 Apr; 25(4):297-300. PubMed ID: 25599912
[TBL] [Abstract][Full Text] [Related]
14. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.
Mendell JR; Sahenk Z; Al-Zaidy S; Rodino-Klapac LR; Lowes LP; Alfano LN; Berry K; Miller N; Yalvac M; Dvorchik I; Moore-Clingenpeel M; Flanigan KM; Church K; Shontz K; Curry C; Lewis S; McColly M; Hogan MJ; Kaspar BK
Mol Ther; 2017 Apr; 25(4):870-879. PubMed ID: 28279643
[TBL] [Abstract][Full Text] [Related]
15. Inclusion body myositis.
Dimachkie MM; Barohn RJ
Neurol Clin; 2014 Aug; 32(3):629-46, vii. PubMed ID: 25037082
[TBL] [Abstract][Full Text] [Related]
16. Association between
Piga D; Zanotti S; Ripolone M; Napoli L; Ciscato P; Gibertini S; Maggi L; Fortunato F; Rigamonti A; Ronchi D; Comi GP; Corti S; Sciacco M
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928252
[TBL] [Abstract][Full Text] [Related]
17. Update on treatment of inclusion body myositis.
Breithaupt M; Schmidt J
Curr Rheumatol Rep; 2013 May; 15(5):329. PubMed ID: 23529584
[TBL] [Abstract][Full Text] [Related]
18. New Developments in the Genetics of Inclusion Body Myositis.
Britson KA; Yang SY; Lloyd TE
Curr Rheumatol Rep; 2018 Apr; 20(5):26. PubMed ID: 29611059
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
[TBL] [Abstract][Full Text] [Related]
20. Unravelling inclusion body myositis using a patient-derived fibroblast model.
Cantó-Santos J; Valls-Roca L; Tobías E; García-García FJ; Guitart-Mampel M; Esteve-Codina A; Martín-Mur B; Casado M; Artuch R; Solsona-Vilarrasa E; Fernandez-Checa JC; García-Ruiz C; Rentero C; Enrich C; Moreno-Lozano PJ; Milisenda JC; Cardellach F; Grau-Junyent JM; Garrabou G
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):964-977. PubMed ID: 36860172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
